364-98-7 | Diazoxide (C₈H₇ClN₂O₂S)

Chemical type

• Potassium channel activator

Key properties

• Inhibits insulin secretion from beta cells; used to manage hyperinsulinemia; helps stabilize blood glucose levels in conditions like insulinoma

• Inhibits insulin secretion by opening KATP channels
• Used in treatment of hyperinsulinemic hypoglycemia
• Administered in delayed-onset transient hyperinsulinism

• Treatment of hyperinsulinemia due to insulinoma; initiated after diagnosis to manage recurrent hypoglycemia in this patient

• Treatment of hyperinsulinism
• Prevention of hypoglycemia

Classification by use

• Agents for hyperinsulinemia and hypoglycemia
• Drugs for endocrine disorders

• Chemicals used to suppress insulin secretion
• Chemicals used in treatment of hypoglycemia
• Chemicals used in pediatric endocrinology

A trustworthy factory and manufacturer

1. [Cite:1] Stevens-Johnson syndrome triggered by phenytoin in a patient with type 2 diabetes and seizures, Exploratory Research in Clinical and Social Pharmacy, Volume 19, September 2025, 100624
2. [Cite:2] Association of Catecholamines with Blood Glucose and Severity of Illness in Infants Born Preterm, The Journal of Pediatrics, Volume 289, February 2026, 114897